跳至主要内容
临床试验/NCT07291154
NCT07291154招募中不适用

Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy

Yunfeng Xia1 个研究点 分布在 1 个国家目标入组 392 人开始时间: 2025年9月22日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
392
试验地点
1
主要终点
mortality rate

研究概览

简要总结

Many maintenance hemodialysis (MHD) patients develop negative outlooks due to their illnesses and complications, making their quality of life and prognosis a clinical concern. Effective life management and treatment cooperation are crucial to improving dialysis quality and patient outcomes. This trial aims to evaluate whether management through the "Yueya" mini-program and WeChat can provide personalized guidance such as health education, diet, exercise, medication supervision, and condition monitoring to enhance treatment compliance, quality of life, strengthen quality control in the hemodialysis unit, and improve patient prognosis.

Patients will be divided into a group receiving support via the "Yueya" mini-program and WeChat, and a control group receiving routine care. Clinical and laboratory indicators, cardiovascular events, death, hospitalization, quality of life, and compliance will be recorded and compared between groups to assess the impact of APP-assisted patient management on the quality of MHD blood purification therapy and the prognosis of MHD patients.

详细描述

Affected by their own diseases and various complications, many maintenance hemodialysis (MHD) patients have a negative and pessimistic attitude toward life. Their quality of life and prognosis have always been a concern for clinicians. Therefore, how to adjust and manage the lives of these patients, enable them to actively cooperate with various treatment methods, maximize the quality of blood purification therapy, and improve their quality of life and prognosis has become an extremely important research topic.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with stage 5 chronic kidney disease, who have received maintenance hemodialysis for more than 3 months, are aged between 18 and 75 years old, and have regular dialysis three times a week.
  • Patients with relatively stable condition, who are able to take care of themselves and willing to cooperate with the study.
  • Patients who can understand and proficiently use WeChat and the "Yueya" mini - program used in this study.

排除标准

  • Patients with communication barriers or other conditions that prevent them from cooperating with the study.
  • Patients who have a history of acute myocardial infarction, cerebral infarction or intracerebral hemorrhage in the past six months.
  • Patients who are not willing to actively cooperate with the study.
  • Patients with severe liver cirrhosis, active tuberculosis and AIDS.

结局指标

主要结局

mortality rate

时间窗: About 1 year

In this study, mortality rate was used as a prognostic indicator.

Hospitalization rate

时间窗: About 1 year

In this study, the hospitalization rate was used as a prognostic indicator.

Kidney Disease Quality of Life

时间窗: About 1 year

Measuring the quality of life of hemodialysis patients through the Kidney Disease Quality of Life-36(KDQOL-36) scale. If the KDQOL-36 score increases, the quality of life is considered to be improved.

Incidence of cardiovascular events

时间窗: About 1 year

次要结局

未报告次要终点

研究者

发起方
Yunfeng Xia
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Yunfeng Xia

Cheif physician

First Affiliated Hospital of Chongqing Medical University

研究点 (1)

Loading locations...

相似试验

Impact of APP-assisted Patient Management on the... | 临床试验